GLP-1 medications carry a boxed warning regarding the risk of thyroid C-cell tumors observed in rodent studies
As many of you know, Ive been on my weight loss & weight maintenance journey in some capacity for 20ish years
Disminuyen el apetito y apoyan la reduccin de peso cuando est indicado
Participants continuing treatment with Zepbound MTD preserved all of their prior weight loss over the 1-year period, while those on the dose reduction maintained all but 5.6 kg on average
The rationale is that glucagon also increases energy expenditure and promotes hepatic fat mobilization, so a molecule that combines glucagons metabolic-rate effect with GLP-1/GIPs appetite-and-glucose control can, in principle, drive weight loss from both sides of the energy-balance equation at once
Already used as a drug to treat hypoglycaemia, DiMarchi began working on finding a better way to synthesise glucagon so that it could be administered more easily